Who Buys Etoposide from India — 598 Importers Behind a $10.8M Market
India's etoposide import market is served by 598 active buyers who collectively imported $10.8M across 2,129 shipments. EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) leads with a 14.0% market share, followed by AMERISOURCE HEALTH SERVICES and FRESENIUS KABI DEUTSCHLAND GMBH. The top 5 buyers together control 29.4% of total import value, reflecting a moderately competitive buyer landscape.
Etoposide buyer data — 598 importers · $10.8M market · 2,129 shipmentsTransData Nexus · Indian Customs Data
Top Etoposide Importers — Ranked by Import Value
EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) is the leading etoposide importer from India, holding a 14.0% share of the $10.8M market across 2,129 shipments from 598 buyers. The top 5 buyers — EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES), AMERISOURCE HEALTH SERVICES (UNITED STATES), FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY), EVERSANA LIFE SCIENCES SERVICES LLC (UNITED STATES), ACCORD FARMA S A DE C V (MEXICO) — collectively control 29.4% of total import value.
Top Etoposide Buyers & Importers
Ranked by import value · 598 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Etoposide Buyers & Importers — Ranked by Import Value. 598 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
PHARMA DRUGS & MEDI ETOPOSIDE INJ,20MG/MPHARMA DRUG&MED:ETOPOSIDEINJUSP,20MG/ML,PHARMA DRUGS & MEDI ETOPOSIDEINJUSP,20MG
$301.3K
74
5
2.8%
8
CSP MYLAN IRELAND LIMITEDFRANCE
ETOPOSIDE VIATRIS 200MG/10ML 10S FRANCE TAX VAL 11526820.13ETOPOSIDE VIATRIS 200MG/10ML 10S FRANCE TAX VAL 11169494.87ETOPOSIDE VIATRIS 200MG/10ML 10S FRANCE TAX VAL 10828569.62
ETOPOSIDE VIATRIS 200MG/10ML 10S FRANCE TAX VAL 11526820.13ETOPOSIDE VIATRIS 200MG/10ML 10S FRANCE TAX VAL 11169494.87ETOPOSIDE VIATRIS 200MG/10ML 10S FRANCE TAX VAL 10828569.62
Which companies are buying Etoposide — and from which countries?
Flow of Etoposide exports from India: each country's share and the named importers behind the numbers
Etoposide — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 48.1% of global Etoposide imports — led by United States (23.1%) with a total trade value of $10.8M across 2,129 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $2.5M through 51 shipments. This represents a market share of 23.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• EVERSANA LIFE SCIENCES SERVICES,LLC - $1.5M (60.8% of country's total business)
• AMERISOURCE HEALTH SERVICES - $507.8K (20.3% of country's total business)
• EVERSANA LIFE SCIENCES SERVICES LLC - $344.7K (13.8% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $49.0K, indicating premium pricing strategy compared to the market average of $5.1K.
United States is a key market for Etoposide imports, representing 23.1% of total trade value.
Primary Market
Secondary Market
2Netherlands
Netherlands emerges as the second largest importing country, achieving a total trade value of through . This represents a market share of of the total market activity, demonstrating their significant presence in the industry.
The importation of Etoposide from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like EVERSANA LIFE SCIENCES SERVICES, LLC and AMERISOURCE HEALTH SERVICES in the United States fall into this category. They procure large volumes to supply hospitals, clinics, and pharmacies, often engaging in long-term contracts to ensure consistent supply.
Hospital Groups: Organizations such as FRESENIUS KABI DEUTSCHLAND GMBH in Germany represent hospital groups. They purchase Etoposide directly for patient treatment, focusing on quality and timely delivery to meet patient needs.
Government Procurement Agencies: While not explicitly listed among the top buyers, entities like UNICEF and The Global Fund often engage in large-scale procurement through tenders to supply public health facilities, emphasizing cost-effectiveness and broad accessibility.
Re-exporters: Companies like BROCACEF NL : HUB in the Netherlands may act as re-exporters, importing Etoposide for redistribution to other markets, leveraging strategic geographic positions and trade agreements.
The demand for Etoposide is driven by several factors:
Disease Prevalence: Etoposide is primarily used in the treatment of various cancers, including lung cancer and testicular cancer. The global incidence of these cancers continues to rise, necessitating increased availability of effective chemotherapeutic agents.
Government Healthcare Programs: Many countries have national cancer control programs that include Etoposide in their treatment protocols, ensuring its procurement and distribution through public health systems.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines, including Etoposide, as governments strive to provide comprehensive cancer care.
WHO Essential Medicines List Procurement: Etoposide's inclusion in the WHO Model List of Essential Medicines facilitates its procurement by international organizations and national health systems, ensuring its availability in resource-limited settings.
Common Questions — Etoposide Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest etoposide buyer importing from India?
Based on import volume and value, EVERSANA LIFE SCIENCES SERVICES,LLC (UNITED STATES) leads with $1.5M in imports and a 14.0% market share — the highest of any single etoposide importer. AMERISOURCE HEALTH SERVICES (UNITED STATES) and FRESENIUS KABI DEUTSCHLAND GMBH (GERMANY) are the next largest buyers.
QHow many companies buy etoposide from India?
There are 598 active etoposide buyers importing from India, with a combined market of $10.8M across 2,129 shipments to 122 countries. The top 5 buyers hold 29.4% of total import value, while the remaining 593 buyers handle the other 70.6%.
QWhich countries import the most etoposide from India?
The top importing countries for etoposide from India are United States (23.1%), Netherlands (9.2%), France (6.9%), Colombia (4.5%), Germany (4.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of etoposide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for etoposide from India?
The average import transaction value for etoposide from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Etoposide from India involves various buyer segments, each with distinct purchasing behaviors:
Distributors: Entities like EVERSANA LIFE SCIENCES SERVICES, LLC and AMERISOURCE HEALTH SERVICES in the United States fall into this category. They procure large volumes to supply hospitals, clinics, and pharmacies, often engaging in long-term contracts to ensure consistent supply.
Hospital Groups: Organizations such as FRESENIUS KABI DEUTSCHLAND GMBH in Germany represent hospital groups. They purchase Etoposide directly for patient treatment, focusing on quality and timely delivery to meet patient needs.
Government Procurement Agencies: While not explicitly listed among the top buyers, entities like UNICEF and The Global Fund often engage in large-scale procurement through tenders to supply public health facilities, emphasizing cost-effectiveness and broad accessibility.
Re-exporters: Companies like BROCACEF NL : HUB in the Netherlands may act as re-exporters, importing Etoposide for redistribution to other markets, leveraging strategic geographic positions and trade agreements.
The demand for Etoposide is driven by several factors:
Disease Prevalence: Etoposide is primarily used in the treatment of various cancers, including lung cancer and testicular cancer. The global incidence of these cancers continues to rise, necessitating increased availability of effective chemotherapeutic agents.
Government Healthcare Programs: Many countries have national cancer control programs that include Etoposide in their treatment protocols, ensuring its procurement and distribution through public health systems.
Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased access to essential medicines, including Etoposide, as governments strive to provide comprehensive cancer care.
WHO Essential Medicines List Procurement: Etoposide's inclusion in the WHO Model List of Essential Medicines facilitates its procurement by international organizations and national health systems, ensuring its availability in resource-limited settings.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
$993.3K
97 shipments
9.2%
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• BROCACEF NL : HUB - $301.3K (30.3% of country's total business)
• ALLOGA FRANCE - $235.4K (23.7% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $10.2K, indicating premium pricing strategy compared to the market average of $5.1K.
Netherlands is a key market for Etoposide imports, representing 9.2% of total trade value.
Primary Market
Secondary Market
3France
France emerges as the third largest importing country, achieving a total trade value of $747.3K through 2 shipments. This represents a market share of 6.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• CSP MYLAN IRELAND LIMITED - $271.6K (36.3% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $373.6K, indicating premium pricing strategy compared to the market average of $5.1K.
France is a key market for Etoposide imports, representing 6.9% of total trade value.
Primary Market
Secondary Market
4Colombia
Colombia emerges as the fourth largest importing country, achieving a total trade value of $485.1K through 3 shipments. This represents a market share of 4.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Colombia has a diverse importer base, with their top importers including:
• ROPSOHN THERAPEUTICS SAS - $335.3K (69.1% of country's total business)
Key Insight: Colombia demonstrates strong market positioning with an average shipment value of $161.7K, indicating premium pricing strategy compared to the market average of $5.1K.
Colombia is a key market for Etoposide imports, representing 4.5% of total trade value.
Primary Market
Secondary Market
5Germany
Germany emerges as the fifth largest importing country, achieving a total trade value of $475.0K through 22 shipments. This represents a market share of 4.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Germany has a diverse importer base, with their top importers including:
• FRESENIUS KABI DEUTSCHLAND GMBH - $475.0K (100.0% of country's total business)
Key Insight: Germany demonstrates strong market positioning with an average shipment value of $21.6K, indicating premium pricing strategy compared to the market average of $5.1K.
Germany is a key market for Etoposide imports, representing 4.4% of total trade value.
Primary Market
Secondary Market
Contract Manufacturers: Entities such as CSP MYLAN IRELAND LIMITED in France might procure Etoposide as an active pharmaceutical ingredient (API) for formulation into finished products, adhering to stringent quality standards and regulatory compliance.
Each segment's purchasing patterns are influenced by factors like regulatory requirements, market demand, and supply chain logistics, necessitating tailored strategies for engagement and supply chain management.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Estimated Timeline: Approximately 210 days for assessment.
Import Tariff/Duty: As an EU member, imports from India may be subject to a 0% duty under the Generalized System of Preferences (GSP).
France:
Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).
Import Registration Process: Submission of a Marketing Authorization Application (MAA) is required.
Estimated Timeline: Around 210 days for evaluation.
Import Tariff/Duty: Under the EU's GSP, imports from India may benefit from reduced or zero tariffs.
Colombia:
Regulatory Authority: National Institute for Food and Drug Surveillance (INVIMA).
Import Registration Process: Requires a Sanitary Registration, including dossier submission and local testing.
Estimated Timeline: Approximately 6 to 12 months.
Import Tariff/Duty: Pharmaceutical products may be subject to a 5% import duty.
Germany:
Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
Import Registration Process: Submission of a Marketing Authorization Application (MAA) is necessary.
Estimated Timeline: Around 210 days for processing.
Import Tariff/Duty: As part of the EU, Germany applies the GSP, potentially allowing for reduced or zero tariffs on imports from India.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many health systems and international organizations utilize tender processes to procure medicines like Etoposide, promoting competitive pricing and ensuring supply chain efficiency.
With 598 buyers across 122 countries, the global market for Etoposide is robust, presenting significant opportunities for suppliers to meet the growing demand driven by these factors.
TransData Nexus Research · Government and regulatory sourcesMar 2026
$5.1K
$4.05 per unit
Contract Manufacturers: Entities such as CSP MYLAN IRELAND LIMITED in France might procure Etoposide as an active pharmaceutical ingredient (API) for formulation into finished products, adhering to stringent quality standards and regulatory compliance.
Each segment's purchasing patterns are influenced by factors like regulatory requirements, market demand, and supply chain logistics, necessitating tailored strategies for engagement and supply chain management.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Estimated Timeline: Approximately 210 days for assessment.
Import Tariff/Duty: As an EU member, imports from India may be subject to a 0% duty under the Generalized System of Preferences (GSP).
France:
Regulatory Authority: French National Agency for Medicines and Health Products Safety (ANSM).
Import Registration Process: Submission of a Marketing Authorization Application (MAA) is required.
Estimated Timeline: Around 210 days for evaluation.
Import Tariff/Duty: Under the EU's GSP, imports from India may benefit from reduced or zero tariffs.
Colombia:
Regulatory Authority: National Institute for Food and Drug Surveillance (INVIMA).
Import Registration Process: Requires a Sanitary Registration, including dossier submission and local testing.
Estimated Timeline: Approximately 6 to 12 months.
Import Tariff/Duty: Pharmaceutical products may be subject to a 5% import duty.
Germany:
Regulatory Authority: Federal Institute for Drugs and Medical Devices (BfArM).
Import Registration Process: Submission of a Marketing Authorization Application (MAA) is necessary.
Estimated Timeline: Around 210 days for processing.
Import Tariff/Duty: As part of the EU, Germany applies the GSP, potentially allowing for reduced or zero tariffs on imports from India.
Compliance with these regulations is essential for market entry and sustained operations in these countries.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Tender-Based Purchasing: Many health systems and international organizations utilize tender processes to procure medicines like Etoposide, promoting competitive pricing and ensuring supply chain efficiency.
With 598 buyers across 122 countries, the global market for Etoposide is robust, presenting significant opportunities for suppliers to meet the growing demand driven by these factors.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 598 global importers of Etoposide identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 2,129 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 122 destination countries with market share per buyer calculated from capped values.
